153 related articles for article (PubMed ID: 7230587)
21. Recent advances concerning the use of muramyl dipeptide derivatives as vaccine potentiators.
Audibert F; Chedid L
Prog Clin Biol Res; 1980; 47():325-38. PubMed ID: 7010376
[No Abstract] [Full Text] [Related]
22. Chemical synthesis and adjuvant activity of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) analogs 1, 2.
Kamisango K; Saiki I; Tanio Y; Kobayashi S; Fukuda T; Sekikawa I; Azuma I; Yamamura Y
Chem Pharm Bull (Tokyo); 1981 Jun; 29(6):1644-54. PubMed ID: 7296716
[No Abstract] [Full Text] [Related]
23. [Induction of epithelioid cell granulomas by muramyl dipeptide].
Tanaka A; Emori K; Nagao S
Kekkaku; 1979 Oct; 54(10):503-4. PubMed ID: 529659
[No Abstract] [Full Text] [Related]
24. Adjuvant activity of mycoloyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in mice and guinea pigs.
Uemiya M; Saiki I; Kusama T; Azuma I; Yamamura Y
Microbiol Immunol; 1979; 23(8):821-3. PubMed ID: 120487
[No Abstract] [Full Text] [Related]
25. Vaccination of experimental monkeys against Plasmodium falciparum: a possible safe adjuvant.
Siddiqui WA; Taylor DW; Kan SC; Kramer K; Richmond-Crum SM; Kotani S; Shiba T; Kusumoto S
Science; 1978 Sep; 201(4362):1237-9. PubMed ID: 99814
[TBL] [Abstract][Full Text] [Related]
26. Biological studies of lipophilic MDP-derivatives incorporated in liposomes.
Jolivet M; Sache E; Audibert F
Immunol Commun; 1981; 10(6):511-22. PubMed ID: 7319546
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and immunoadjuvant activities of muramoyl-L-alanyl-D-isoglutamine and some carbohydrate analogs.
Kiso M; Kaneda Y; Okumura H; Hasegawa A; Azuma I; Yamamura Y
Carbohydr Res; 1980 Feb; 79(1):C17-9. PubMed ID: 7357566
[No Abstract] [Full Text] [Related]
28. Adjuvant activity of 6-O-mycoloyl derivatives of N-acetylmuramyl-L-seryl-D-isoglutamine and related compounds in mice and guinea pigs.
Uemiya M; Sugimura K; Kusama T; Saiki I; Yamawaki M; Azuma I; Yamamura Y
Infect Immun; 1979 Apr; 24(1):83-9. PubMed ID: 313372
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant and antitumor activities of quinonyl-N-acetylmuramyldipeptides.
Azuma I; Yamawaki M; Uemiya M; Saiki I; Tanio Y; Kobayashi S; Fukuda T; Imada I; Yamamura Y
Gan; 1979 Dec; 70(6):847-8. PubMed ID: 535688
[No Abstract] [Full Text] [Related]
30. Adjuvant activity of muramyldipeptide in a guinea pig model of contact allergy to chromium.
Jírová D; Janecková V; Znojemská S; Pekárek J
J Hyg Epidemiol Microbiol Immunol; 1983; 27(4):395-402. PubMed ID: 6663072
[TBL] [Abstract][Full Text] [Related]
31. Immunoadjuvant activity of synthetic N-acetyl muramyl dipeptide.
Masek K; Zaoral M; Jezek J; Straka R
Experientia; 1978 Oct; 34(10):1363-4. PubMed ID: 738426
[No Abstract] [Full Text] [Related]
32. Past, present and future of the synthetic immunoadjuvant MDP and its analogs.
Chedid L; Lederer E
Biochem Pharmacol; 1978; 27(18):2183-6. PubMed ID: 365182
[No Abstract] [Full Text] [Related]
33. Synthesis of N-acetyl-6-amino- and -6-(acylamino)-6-deoxymuramoyl dipeptides, and their immunoadjuvant activities.
Hasegawa A; Okumura H; Kiso M; Azuma I; Yamamura Y
Carbohydr Res; 1980 Feb; 79(1):C20-3. PubMed ID: 7357567
[No Abstract] [Full Text] [Related]
34. Muramyl dipeptide-induced adjuvant arthritis.
Nagao S; Tanaka A
Infect Immun; 1980 May; 28(2):624-6. PubMed ID: 7399679
[TBL] [Abstract][Full Text] [Related]
35. Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity.
Chedid LA; Parant MA; Audibert FM; Riveau GJ; Parant FJ; Lederer E; Choay JP; Lefrancier PL
Infect Immun; 1982 Feb; 35(2):417-24. PubMed ID: 7035362
[TBL] [Abstract][Full Text] [Related]
36. Macrophage-stimulating effect of a synthetic muramyl dipeptide and its adjuvant-active and -inactive analogs for the production of T-cell activating monokines.
Iribe H; Koga T; Onoue K; Kotani S; Kusumoto S; Shiba T
Cell Immunol; 1981 Oct; 64(1):73-83. PubMed ID: 7028277
[No Abstract] [Full Text] [Related]
37. [Immunopharmacological activities of bacterial cell walls and related synthetic compounds (muramyl peptides)].
Kotani S; Takada H
Yakugaku Zasshi; 1983 Jan; 103(1):1-27. PubMed ID: 6191019
[No Abstract] [Full Text] [Related]
38. [Chemical synthesis and immunologic activities of the active unit of BCG-CWS].
Saiki I; Azuma I
Nihon Rinsho; 1981 Apr; 39(4):1861-7. PubMed ID: 7031298
[No Abstract] [Full Text] [Related]
39. The adjuvant activity of synthetic N-acetylmuramyl-dipeptide: evidence of initial target cells for the adjuvant activity.
Sugimura K; Uemiya M; Saiki I; Azuma I; Yamamura Y
Cell Immunol; 1979 Mar; 43(1):137-49. PubMed ID: 313841
[No Abstract] [Full Text] [Related]
40. Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents.
Chedid L; Audibert F; Johnson AG
Prog Allergy; 1978; 25():63-105. PubMed ID: 362430
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
